Related Experiment Video
Updated: May 24, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
The p53 circuit board
Kelly D Sullivan1, Corrie L Gallant-Behm, Ryan E Henry
1Howard Hughes Medical Institute & Department of Molecular, Cellular and Developmental Biology, The University of Colorado at Boulder, Boulder, CO 80309-0347, USA.
Abstract:
The p53 tumor suppressor is embedded in a large gene network controlling diverse cellular and organismal phenotypes. Multiple signaling pathways converge onto p53 activation, mostly by relieving the inhibitory effects of its repressors, MDM2 and MDM4. In turn, signals originating from increased p53 activity diverge into distinct effector pathways to deliver a specific cellular response to the activating stimuli. Much attention has been devoted to dissecting how the various input pathways trigger p53 activation and how the activity of the p53 protein itself can be modulated by a plethora of co-factors and post-translational modifications. In this review we will focus instead on the multiple configurations of the effector pathways. We will discuss how p53-generated signals are transmitted, amplified, resisted and eventually integrated by downstream gene circuits operating at the transcriptional, post-transcriptional and post-translational levels. We will also discuss how context-dependent variations in these gene circuits define the cellular response to p53 activation and how they may impact the clinical efficacy of p53-based targeted therapies.
Insights
The p53 tumor suppressor protein regulates cell functions through complex gene networks. This review explores how p53 signals are transmitted and modified by downstream pathways, impacting cellular responses and therapies.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Biology
Background:
- The p53 tumor suppressor is a key regulator of cellular phenotypes, influenced by numerous signaling pathways.
- MDM2 and MDM4 are critical repressors of p53, and their inhibition is a major route to p53 activation.
- While p53 activation mechanisms are well-studied, its downstream effector pathways are less understood.
Purpose of the Study:
- To review the configurations of p53 effector pathways.
- To discuss signal transmission, amplification, and integration by downstream gene circuits.
- To explore how variations in these circuits affect cellular responses and p53-based therapies.
Main Methods:
- Literature review focusing on p53 effector pathways.
- Analysis of transcriptional, post-transcriptional, and post-translational regulatory mechanisms.
- Discussion of context-dependent variations in gene circuits.
Main Results:
- p53 signals diverge into distinct effector pathways to mediate specific cellular responses.
- Downstream gene circuits at multiple molecular levels transmit, amplify, and integrate p53-generated signals.
- Variations in these circuits contribute to diverse cellular outcomes and influence therapeutic strategies.
Conclusions:
- Understanding p53 effector pathway configurations is crucial for deciphering cellular responses.
- Context-dependent regulation of p53 signaling impacts the effectiveness of targeted cancer therapies.
- Further research into these downstream circuits may reveal new therapeutic targets.
Related Concept Videos
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
The Intrinsic Apoptotic Pathway
PI Controller: Design

